PDA Delaware Valley Chapter: Current FDA CBER Regulatory Initiatives and Vendor Night
Registration Options
Individual Registration
Group Registration
Join the PDA DEL VAL membership for our meeting entitled, “Current FDA CBER Initiatives” coupled with our Annual Vendor Night Extravaganza at the Desmond Hotel and Convention Center in Malvern, PA.
The evening will start with our Annual Vendor Night Extravaganza which will feature 40 vendors displays in the Foyer and Main Room of the Desmond Hotel. Included will be food stations, beverages, a cash bar and 40 vendor raffles. Per the schedule below, the presentation on “Current FDA Initiatives” will be conducted in the Amphitheater of the Desmond Hotel (3rd Floor of Conference Center). This presentation will focus on what current and upcoming FDA Center for Biologics (CBER) initiatives exist in the industry relating to sterile manufacturing and testing operations.
This is a must-see presentation! Please register early as space will be limited.
Sponorship Opportunity
We are pleased to be able to offer sponsors the opportunity to support this event. Sponsorship inclues a table top display at one meeting and registration for two attendees (including food and speaking event). The cost per table is $800.00.
Event Location
One Liberty Blvd., Malvern, PA 19355 Get DirectionsContact
Chapter Inquiries
Membership Services
Ticket price is $80.00
Day 1
4:00pm - 7:15pm | Networking, food stations, beverages, a cash bar and vendor raffles in Exhibit Hall
7:15pm - 9:00pm | Presentation
Featured Presenters
-
Daniel DeCiero
Consumer Safety Officer, OCBQ, CBER, U.S. FDA
Read Bio
Daniel DeCiero
U.S. FDA
Daniel DeCiero is the Branch Chief of the Biological Drug and Device Compliance Branch in CBER’s Office of Compliance Biologics Quality (OCBQ), where he oversees reviews and evaluations of compliance and enforcement actions for biological products, drugs and devices regulated by CBER. He has been at the Agency since 2015 and was previously a Process and Facilities reviewer in CDER’s Office of Process and Facilities. In this role, he assessed proposed manufacturing and testing processes for filed drug applications (ANDA/NDA), including performing and assessing pre-approval inspections for related manufacturing facilities. Prior to joining FDA, he worked in systems engineering at General Dynamics and at Merck performing laboratory and pilot-plant scale development of APIs. He has a MS degree in Regulatory Science from the University of Maryland Baltimore and a BS degree in Chemical Engineering from Worcester Polytechnic Institute.
PLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.